Skip to main content
OpenTrials
Completed

NCT Number: NCT06755905

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's hospital of nanjing medical university

Nanjing, Jiangsu, 210008, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • No previous intervention
  • more than 6 months post-treatment follow-up
  • Stage I or Stage IIa

Exclusion criteria

  • History of iodine allergy
  • Syndromic cLM
  • Severe liver and kidney dysfunction

Treatment and study plan

ICGL-guided treatment

Procedure

Indocyanine green lymphography guided resection combined with sclerotherapy

Conventional Treatment group

Procedure

Resection with sclerotherapy

Primary outcomes

  1. Cured (Reduction in dimension greater than 90%)

    Time frame: From enrollment to the end of treatment at 12 weeks

    Reduction in dimension greater than 90%

Sponsors and collaborators

Lead sponsor

Nanjing Children's Hospital

Other

Registry information

Official study title

Application Value of Indocyanine Green Lymphography in Management of Microcystic Lymphatic Malformation of the Tongue

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Jan 1, 2025
Registry last updated
Mar 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.